CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.20 ($410,000)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $7.97 ($79,700)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $7.90 ($394,750)
- 4 Open-market buy 10% owner bought 33,100 shares at $7.03 ($232,693)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $7.39 ($73,900)
- 4 Open-market buy 10% owner bought 66,400 shares at $7.28 ($483,392)
- 4 Open-market buy 10% owner bought 14,200 shares at $7.28 ($103,376)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $7.67 ($383,500)
- 4 Open-market buy 10% owner bought 120,475 shares at an average $7.89 ($950,632)
- 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $7.85 ($31,400)
- 4 Open-market buy 10% owner bought 143,000 shares at an average $7.91 ($1,130,590)
- 4 Open-market buy 10% owner bought 217,700 shares at an average $8.00 ($1,742,226)
- 4 Open-market buy 10% owner bought 900 shares at $8.31 ($7,479)
- 4 Gift President and CEO gave 14,000 shares (gift)
- 4 Open-market buy 10% owner bought 13,900 shares at $8.36 ($116,204)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.42 ($420,750)
- 4 Open-market buy 10% owner bought 18,900 shares at $8.38 ($158,382)
- 4 Open-market buy 10% owner bought 8,400 shares at an average $8.42 ($70,694)
- 4 Other acquisition President and CEO acquired 28,201 shares (other)
- 4 Open-market buy 10% owner bought 20,400 shares at an average $8.42 ($171,687)
Page 23 of 30 · 591 filings